Cancer Research Meeting Calendar Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Etoh, T.
Right arrow Articles by Mori, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Etoh, T.
Right arrow Articles by Mori, M.
[Cancer Research 61, 2145-2153, March 1, 2001]
© 2001 American Association for Cancer Research

Tumor Biology

Angiopoietin-2 Is Related to Tumor Angiogenesis in Gastric Carcinoma

Possible in Vivo Regulation via Induction of Proteases1

Tsuyoshi Etoh, Hiroshi Inoue, Shinji Tanaka, Graham F. Barnard, Seigo Kitano and Masaki Mori2

Department of Surgery, Medical Institute of Bioregulation, Kyushu University, Beppu 874-0838, Japan [T. E., H. I., M. M.]; Department of Surgery II, Kyushu University, Fukuoka, Japan [S. T.]; Division of Digestive Disease and Nutrition, University of Massachusetts Medical School, Worcester, MA [G. F. B.]; and Department of Surgery I, Faculty of Medicine, Oita Medical University, Oita, Japan [T. E., S. K.]

Tumor angiogenesis progresses by a dynamic balance between tumor vascular regression and growth. Angiopoietin (Ang)-2 (the natural antagonist for the angiogenic Tie-2 receptor) and vascular endothelial growth factor (VEGF) are thought to be critical regulators in this process; therefore, these may play a critical role in cancer aggressiveness. The aim of this study was to clarify the clinical and biological significance of the expression of Ang-2 in human gastric cancers and to investigate the relationship between Ang-2 together with VEGF and the induction of proteases such as matrix metalloproteinases (MMPs) in the process of tumor development. Eighty-five individuals with gastric cancer, who had undergone surgery without preoperative treatment, were studied. A stable transfectant of the human MKN-7 gastric cancer cell lines with an Ang-2 expression vector was used for the experimental study. First, we examined the relationship between the mRNA expression of Angs by Northern blot analysis and clinicopathological features. High Ang-2-expression cases showed more frequent vascular involvement and more advanced stages of disease compared with low Ang-2-expression cases (P < 0.05). With regard to prognosis, the survival time for patients in the high-Ang-2 mRNA group was significantly shorter (P < 0.05). When we examined the localization of Ang-2 in human gastric cancers, immunohistochemical analysis revealed that this protein was expressed predominantly in cancer tissues when compared with normal tissues. Interestingly it was expressed not only in endothelia cells (ECs) but also in cancer cells. Second, Ang-2-transfected cells were implanted in vivo into the gastric walls of nude mice. Ang-2-transfectant mice developed highly metastatic tumors with hypervascularity as compared with MKN-7 or control vector-transfectant tumors. There was a significant correlation between Ang-2 mRNA expression and lower grade of vessel maturation. Third, on the basis of the in vivo data, we focused on production of proteases such as MMPs to investigate possible mechanisms in these processes. MMP-1, MMP-9, and urokinase-type plasminogen activator in ECs were strongly up-regulated by Ang-2 in the presence of VEGF in vitro. These data suggest that production of Ang-2 is implicated in tumor development in human gastric cancers. Its production may contribute to tumor angiogenesis by induction of proteases in ECs, which may be enhanced in the presence of VEGF.




This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
B. L. Falcon, H. Hashizume, P. Koumoutsakos, J. Chou, J. V. Bready, A. Coxon, J. D. Oliner, and D. M. McDonald
Contrasting Actions of Selective Inhibitors of Angiopoietin-1 and Angiopoietin-2 on the Normalization of Tumor Blood Vessels
Am. J. Pathol., November 1, 2009; 175(5): 2159 - 2170.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
R Srirajaskanthan, G Dancey, A Hackshaw, T Luong, M E Caplin, and T Meyer
Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosis
Endocr. Relat. Cancer, September 1, 2009; 16(3): 967 - 976.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. S. Herbst, D. Hong, L. Chap, R. Kurzrock, E. Jackson, J. M. Silverman, E. Rasmussen, Y.-N. Sun, D. Zhong, Y. C. Hwang, et al.
Safety, Pharmacokinetics, and Antitumor Activity of AMG 386, a Selective Angiopoietin Inhibitor, in Adult Patients With Advanced Solid Tumors
J. Clin. Oncol., July 20, 2009; 27(21): 3557 - 3565.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Nasarre, M. Thomas, K. Kruse, I. Helfrich, V. Wolter, C. Deppermann, D. Schadendorf, G. Thurston, U. Fiedler, and H. G. Augustin
Host-Derived Angiopoietin-2 Affects Early Stages of Tumor Development and Vessel Maturation but Is Dispensable for Later Stages of Tumor Growth
Cancer Res., February 15, 2009; 69(4): 1324 - 1333.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
K. Anargyrou, E. Terpos, T. P. Vassilakopoulos, A. Pouli, S. Sachanas, T. Tzenou, S. Masouridis, D. Christoulas, M. K. Angelopoulou, E. M. Dimitriadou, et al.
Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib
Haematologica, March 1, 2008; 93(3): 451 - 454.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. L. Tressel, R.-P. Huang, N. Tomsen, and H. Jo
Laminar Shear Inhibits Tubule Formation and Migration of Endothelial Cells by an Angiopoietin-2-Dependent Mechanism
Arterioscler Thromb Vasc Biol, October 1, 2007; 27(10): 2150 - 2156.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
W. S.N. Shim, I. A.W. Ho, and P. E.H. Wong
Angiopoietin: A TIE(d) Balance in Tumor Angiogenesis
Mol. Cancer Res., July 1, 2007; 5(7): 655 - 665.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
L. Bezuidenhout, M. Bracher, G. Davison, P. Zilla, and N. Davies
Ang-2 and PDGF-BB cooperatively stimulate human peripheral blood monocyte fibrinolysis
J. Leukoc. Biol., June 1, 2007; 81(6): 1496 - 1503.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. J. Vart, L. L. Nikitenko, D. Lagos, M. W.B. Trotter, M. Cannon, D. Bourboulia, F. Gratrix, Y. Takeuchi, and C. Boshoff
Kaposi's Sarcoma-Associated Herpesvirus-Encoded Interleukin-6 and G-Protein-Coupled Receptor Regulate Angiopoietin-2 Expression in Lymphatic Endothelial Cells
Cancer Res., May 1, 2007; 67(9): 4042 - 4051.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Imanishi, B. Hu, M. J. Jarzynka, P. Guo, E. Elishaev, I. Bar-Joseph, and S.-Y. Cheng
Angiopoietin-2 Stimulates Breast Cancer Metastasis through the {alpha}5{beta}1 Integrin-Mediated Pathway
Cancer Res., May 1, 2007; 67(9): 4254 - 4263.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
F.-C. Ye, D. J. Blackbourn, M. Mengel, J.-P. Xie, L.-W. Qian, W. Greene, I-T. Yeh, D. Graham, and S.-J. Gao
Kaposi's Sarcoma-Associated Herpesvirus Promotes Angiogenesis by Inducing Angiopoietin-2 Expression via AP-1 and Ets1
J. Virol., April 15, 2007; 81(8): 3980 - 3991.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Niu and W. B. Carter
Human Epidermal Growth Factor Receptor 2 Regulates Angiopoietin-2 Expression in Breast Cancer via AKT and Mitogen-Activated Protein Kinase Pathways
Cancer Res., February 15, 2007; 67(4): 1487 - 1493.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
T. N. H. Masckauchan, D. Agalliu, M. Vorontchikhina, A. Ahn, N. L. Parmalee, C.-M. Li, A. Khoo, B. Tycko, A. M.C. Brown, and J. Kitajewski
Wnt5a Signaling Induces Proliferation and Survival of Endothelial Cells In Vitro and Expression of MMP-1 and Tie-2
Mol. Biol. Cell, December 1, 2006; 17(12): 5163 - 5172.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
J Heidemann, D G Binion, W Domschke, and T Kucharzik
Antiangiogenic therapy in human gastrointestinal malignancies.
Gut, October 1, 2006; 55(10): 1497 - 1511.
[Full Text] [PDF]

Home page
 JNMHome page
P. Kunz, J. Hoffend, A. Altmann, A. Dimitrakopoulou-Strauss, D. Koczan, M. Eisenhut, G. A. Bonaterra, T. J. Dengler, W. Mier, U. Haberkorn, et al.
Angiopoietin-2 Overexpression in Morris Hepatoma Results in Increased Tumor Perfusion and Induction of Critical Angiogenesis-Promoting Genes
J. Nucl. Med., September 1, 2006; 47(9): 1515 - 1524.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
W. Bureau, P. Van Slyke, J. Jones, R. N. N. Han, N. L. Ward, D. J. Stewart, and D. J. Dumont
Chronic systemic delivery of angiopoietin-2 reveals a possible independent angiogenic effect
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H948 - H956.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
S. E. Hur, J. Y. Lee, H.-S. Moon, and H. W. Chung
Angiopoietin-1, angiopoietin-2 and Tie-2 expression in eutopic endometrium in advanced endometriosis
Mol. Hum. Reprod., July 1, 2006; 12(7): 421 - 426.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Hu, M. J. Jarzynka, P. Guo, Y. Imanishi, D. D. Schlaepfer, and S.-Y. Cheng
Angiopoietin 2 Induces Glioma Cell Invasion by Stimulating Matrix Metalloprotease 2 Expression through the {alpha}v{beta}1 Integrin and Focal Adhesion Kinase Signaling Pathway
Cancer Res., January 15, 2006; 66(2): 775 - 783.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
H Yoshiji, S Kuriyama, R Noguchi, J Yoshii, Y Ikenaka, K Yanase, T Namisaki, M Kitade, M Uemura, T Masaki, et al.
Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice
Gut, December 1, 2005; 54(12): 1768 - 1775.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
Y. Zhu, C. Lee, F. Shen, R. Du, W. L. Young, and G.-Y. Yang
Angiopoietin-2 Facilitates Vascular Endothelial Growth Factor-Induced Angiogenesis in the Mature Mouse Brain
Stroke, July 1, 2005; 36(7): 1533 - 1537.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. Guo, Y. Imanishi, F. C. Cackowski, M. J. Jarzynka, H.-Q. Tao, R. Nishikawa, T. Hirose, B. Hu, and S.-Y. Cheng
Up-Regulation of Angiopoietin-2, Matrix Metalloprotease-2, Membrane Type 1 Metalloprotease, and Laminin 5 {gamma} 2 Correlates with the Invasiveness of Human Glioma
Am. J. Pathol., March 1, 2005; 166(3): 877 - 890.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. R. Machein, A. Knedla, R. Knoth, S. Wagner, E. Neuschl, and K. H. Plate
Angiopoietin-1 Promotes Tumor Angiogenesis in a Rat Glioma Model
Am. J. Pathol., November 1, 2004; 165(5): 1557 - 1570.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Xu, Y.-j. Liu, and Q. Yu
Angiopoietin-3 Inhibits Pulmonary Metastasis by Inhibiting Tumor Angiogenesis
Cancer Res., September 1, 2004; 64(17): 6119 - 6126.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. Y. Chong, G. J. Caine, B. Freestone, A. D. Blann, and G. Y. H. Lip
Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure
J. Am. Coll. Cardiol., February 4, 2004; 43(3): 423 - 428.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Hu, P. Guo, Q. Fang, H.-Q. Tao, D. Wang, M. Nagane, H.-J. Su Huang, Y. Gunji, R. Nishikawa, K. Alitalo, et al.
Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2
PNAS, July 22, 2003; 100(15): 8904 - 8909.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
N. Giuliani, S. Colla, M. Lazzaretti, R. Sala, G. Roti, C. Mancini, S. Bonomini, P. Lunghi, M. Hojden, G. Genestreti, et al.
Proangiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis
Blood, July 15, 2003; 102(2): 638 - 645.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Zhang, N. Yang, J.-W. Park, D. Katsaros, S. Fracchioli, G. Cao, A. O'Brien-Jenkins, T. C. Randall, S. C. Rubin, and G. Coukos
Tumor-derived Vascular Endothelial Growth Factor Up-Regulates Angiopoietin-2 in Host Endothelium and Destabilizes Host Vasculature, Supporting Angiogenesis in Ovarian Cancer
Cancer Res., June 15, 2003; 63(12): 3403 - 3412.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. R. White, S. Shan, C. P. Rusconi, G. Shetty, M. W. Dewhirst, C. D. Kontos, and B. A. Sullenger
Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2
PNAS, April 29, 2003; 100(9): 5028 - 5033.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
T. Hashimoto, G. Wen, M. T. Lawton, N. J. Boudreau, A. W. Bollen, G.-Y. Yang, N. M. Barbaro, R. T. Higashida, C. F. Dowd, V. V. Halbach, et al.
Abnormal Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Brain Arteriovenous Malformations * Growth and Bleeding in BAVM: Another Role for MMPs
Stroke, April 1, 2003; 34(4): 925 - 931.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Etoh, Y. Himeno, T. Matsumoto, M. Aramaki, K. Kawano, A. Nishizono, and S. Kitano
Oncolytic Viral Therapy for Human Pancreatic Cancer Cells by Reovirus
Clin. Cancer Res., March 1, 2003; 9(3): 1218 - 1223.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Tanaka, S. Ishikawa, K. Yanagihara, R. Miyahara, Y. Kawano, M. Li, Y. Otake, and H. Wada
Expression of Angiopoietins and Its Clinical Significance in Non-Small Cell Lung Cancer
Cancer Res., December 1, 2002; 62(23): 7124 - 7129.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
W. W. Spurbeck, C. Y. C. Ng, T. S. Strom, E. F. Vanin, and A. M. Davidoff
Enforced expression of tissue inhibitor of matrix metalloproteinase-3 affects functional capillary morphogenesis and inhibits tumor growth in a murine tumor model
Blood, October 16, 2002; 100(9): 3361 - 3368.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
I. B. Lobov, P. C. Brooks, and R. A. Lang
From the Cover: Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo
PNAS, August 20, 2002; 99(17): 11205 - 11210.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Tanaka, H. Sonoo, J. Kurebayashi, T. Nomura, S. Ohkubo, Y. Yamamoto, and S. Yamamoto
Inhibition of Infiltration and Angiogenesis by Thrombospondin-1 in Papillary Thyroid Carcinoma
Clin. Cancer Res., May 1, 2002; 8(5): 1125 - 1131.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Hawighorst, M. Skobe, M. Streit, Y.-K. Hong, P. Velasco, L. F. Brown, L. Riccardi, B. Lange-Asschenfeldt, and M. Detmar
Activation of the Tie2 Receptor by Angiopoietin-1 Enhances Tumor Vessel Maturation and Impairs Squamous Cell Carcinoma Growth
Am. J. Pathol., April 1, 2002; 160(4): 1381 - 1392.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. I. Deryugina, L. Soroceanu, and A. Y. Strongin
Up-Regulation of Vascular Endothelial Growth Factor by Membrane-type 1 Matrix Metalloproteinase Stimulates Human Glioma Xenograft Growth and Angiogenesis
Cancer Res., January 1, 2002; 62(2): 580 - 588.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
Y. Mochizuki, T. Nakamura, H. Kanetake, and S. Kanda
Angiopoietin 2 stimulates migration and tube-like structure formation of murine brain capillary endothelial cells through c-Fes and c-Fyn
J. Cell Sci., January 1, 2002; 115(1): 175 - 183.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.